Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Hair loss doesn't affect COVID-19 severity.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Some drugs may help treat both COVID-19 and radiation injury.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.